Integrating glutathione metabolism and mitochondrial dysfunction with implications for Parkinson's disease: A dynamic model

Neuroscience

Volumn 149, Issue 4, 2007, Pages 917-930

  Vali, S ^a,b   Mythri, R B ^d   Jagatha, B ^d   Padiadpu, J ^a,b   Ramanujan, K S ^a,b   Andersen, J K ^e   Gorin, F ^b,c   Bharath, M M S ^d  

^a Cell Works Group Inc   (India)

^b School of Medicine ^*  (United States)

^c WF Goodman Center for Comparative Medical Genetics School of Veterinary Medicine   (United States)

^d NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

^e BUCK INSTITUTE FOR RESEARCH ON AGING   (United States)

Author keywords

mitochondrial bioenergetics; neurodegeneration; nitric oxide; oxidative stress; peroxynitrite; rotenone

Indexed keywords

GLUTATHIONE; NITRIC OXIDE; PEROXYNITRITE; ROTENONE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL VIABILITY; DISEASE COURSE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; GLUTATHIONE METABOLISM; IN VITRO STUDY; NERVE DEGENERATION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN SYNTHESIS; RAT; RESPIRATORY CHAIN;

EID: 36249019785     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2007.08.028     Document Type: Article

References (52)

1. Adams Jr. J.D., Chang M.L., and Klaidman L. Parkinson's disease: redox mechanisms. Curr Med Chem 8 (2001) 809-814
2. Adams F.S., La Rosa F.G., Kumar S., Edwards-Prasad J., Kentroti S., Vernadakis A., Freed C.R., and Prasad K.N. Characterization and transplantation of two neuronal cell lines with dopaminergic properties. Neurochem Res 21 (1996) 619-627
3. Beal M.F. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?. Ann Neurol 31 (1992) 119-130
4. Bernstein B.W., and Bamburg J.R. Actin-ATP hydrolysis is a major energy drain for neurons. J Neurosci 23 (2003) 1-6
5. Betarbet R., Sherer T.B., MacKenzie G., Garcia-Osuna M., Panov A.V., and Greenamyre J.T. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci 3 (2000) 1301-1306
6. Bharath M.M., and Andersen J.K. Glutathione depletion in a midbrain-derived immortalized dopaminergic cell line results in limited tyrosine nitration of mitochondrial complex I subunits: implications for Parkinson's disease. Antioxid Redox Signal 7 (2005) 900-910
7. Bharath S., Hsu M., Kaur D., Rajagopalan S., and Andersen J.K. Glutathione, iron and Parkinson's disease. Biochem Pharmacol 64 (2002) 1037-1048
8. Blanchard-Fillion B., Prou D., Polydoro M., Spielberg D., Tsika E., Wang Z., Hazen S.L., Koval M., and Przedborski S Ischiropoulos H. Metabolism of 3-nitrotyrosine induces apoptotic death in dopaminergic cells. J Neurosci 26 (2006) 6124-6130
9. Burke R.E. Parkinson's disease. In: Koliatsos V.E., and Ratan R.R. (Eds). Cell death and disease of the nervous system (1998), Humana Press, Totowa, NJ 459-475
10. Cadenas E., and Davies K.J. Mitochondrial free radical generation, oxidative stress, and aging. Free Radic Biol Med 29 (2000) 222-230
11. Chen T.S., Richie Jr. J.P., and Lang C.A. The effect of aging on glutathione and cysteine levels in different regions of the mouse brain. Proc Soc Exp Biol Med 190 (1989) 399-402
12. Chen Y., Shertzer H.G., Schneider S.N., Nebert D.W., and Dalton T.P. Glutamate cysteine ligase catalysis: dependence on ATP and modifier subunit for regulation of tissue glutathione levels. J Biol Chem 280 (2005) 33766-33774
13. Chinta S.J., and Andersen J.K. Reversible inhibition of mitochondrial complex I activity following chronic dopaminergic glutathione depletion in vitro: implications for Parkinson's disease. Free Radic Biol Med 41 (2006) 1442-1448
14. Chinta S.J., Kumar J.M., Zhang H., Forman H.J., and Andersen J.K. Up-regulation of gamma-glutamyl transpeptidase activity following glutathione depletion has a compensatory rather than an inhibitory effect on mitochondrial complex I activity: implications for Parkinson's disease. Free Radic Biol Med 40 (2006) 1557-1563
15. Chung K.K., Dawson T.M., and Dawson V.L. Nitric oxide, S-nitrosylation and neurodegeneration. Cell Mol Biol (Noisy-le-Grand) 51 (2005) 247-254
16. Clarkson E.D., Rosa F.G., Edwards-Prasad J., Weiland D.A., Witta S.E., Freed C.R., and Prasad K.N. Improvement of neurological deficits in 6-hydroxydopamine-lesioned rats after transplantation with allogeneic simian virus 40 large tumor antigen gene-induced immortalized dopamine cells. Proc Natl Acad Sci U S A 95 (1998) 1265-1270
17. Clementi E., Brown G.C., Feelisch M., and Moncada S. Persistent inhibition of cell respiration by nitric oxide: crucial role of S-nitrosation of mitochondrial complex I and protective action of glutathione. Proc Natl Acad Sci U S A 95 (1998) 7631-7636
18. Giulivi C., Poderoso J.J., and Boveris A. Production of nitric oxide by mitochondria. J Biol Chem 273 (1998) 11038-11043
19. Hsu M., Srinivas B., Kumar J., Subramanian R., and Andersen J. Glutathione depletion resulting in selective mitochondrial complex I inhibition in dopaminergic cells is via an NO-mediated pathway not involving peroxynitrite: implications for Parkinson's disease. J Neurochem 92 (2005) 1091-1103
20. Huang J., and Philbert M.A. Distribution of glutathione and glutathione-related enzyme systems in mitochondria and cytosol of cultured cerebellar astrocytes and granule cells. Brain Res 680 (1995) 16-22
21. Huang J., and Philbert M.A. Cellular responses of cultured cerebellar astrocytes to ethacrynic acid-induced perturbation of subcellular glutathione homeostasis. Brain Res 711 (1996) 184-192
22. Jenner P. Altered mitochondrial function, iron metabolism and glutathione levels in Parkinson's disease. Acta Neurol Scand Suppl 146 (1993) 6-13
23. Jezek P., and Hlavata L. Mitochondria in homeostasis of reactive oxygen species in cell, tissues, and organism. Int J Biochem Cell Biol 37 (2005) 2478-2503
24. Jha N., Jurma O., Lalli G., Liu Y., Pettusi E.H., Greenamyre J.T., Liu R.M., Forman H.J., and Andersen J.K. Glutathione depletion in PC12 results in selective inhibition of mitochondrial complex I activity: implications for Parkinson's disease. J Biol Chem 275 (2000) 26096-27001
25. Jin Q., and Bethke C.M. Kinetics of electron transfer through the respiratory chain. Biophys J 83 (2002) 1797-1808
26. Kadenbach B. Intrinsic and extrinsic uncoupling of oxidative phosphorylation. Biochim Biophys Acta 1604 (2003) 77-94
27. Kang Y., Viswanath V., Jha N., Qiao X., Mo J.Q., and Andersen J.K. Brain gamma-glutamyl cysteine synthetase (GCS) mRNA expression patterns correlate with regional-specific enzyme activities and glutathione levels. J Neurosci Res 58 3 (1999) 436-441
28. Kaushik P., Gorin F., and Vali S. Dynamics of tyrosine hydroxylase mediated regulation of dopamine synthesis. J Comput Neurosci 22 (2007) 147-160
29. Keeney P.M., Xie J., Capaldi R.A., and Bennett Jr. J.P. Parkinson's disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled. J Neurosci 26 (2006) 5256-5264
30. Lenaz G., Bovina C., Castelluccio C., Fato R., Formiggini G., Genova M.L., Marchetti M., Pich M.M., Pallotti F., Parenti Castelli G., and Biagini G. Mitochondrial complex I defects in aging. Mol Cell Biochem 178 (1997) 329-333
31. Lin T.K., Hughes G., Muratovska A., Blaikie F.H., Brookes P.S., Darley-Usmar V., Smith R.A., and Murphy M.P. Specific modification of mitochondrial protein thiols in response to oxidative stress: a proteomics approach. J Biol Chem 277 (2002) 17048-17056
32. Meister A. Glutathione metabolism and its selective modification. J Biol Chem 263 (1988) 17205-17208
33. Moncada S., and Bolanos J.P. Nitric oxide, cell bioenergetics and neurodegeneration. J Neurochem 97 (2006) 1676-1689
34. Murray J., Taylor S.W., Zhang B., Ghosh S.S., and Capaldi R.A. Oxidative damage to mitochondrial complex I due to peroxynitrite: identification of reactive tyrosines by mass spectrometry. J Biol Chem 278 (2003) 37223-37230
35. Muyderman H., Nilsson M., and Sims N.R. Highly selective and prolonged depletion of mitochondrial glutathione in astrocytes markedly increases sensitivity to peroxynitrite. J Neurosci 24 (2004) 8019-8028
36. Mythri R.B., Jagatha B., Pradhan N., Andersen J., and Bharath M.M. Mitochondrial complex I inhibition in Parkinson's disease: how can curcumin protect mitochondria?. Antioxid Redox Signal 9 (2007) 399-408
37. Nunes C., Almeida L., and Laranjinha J. Synergistic inhibition of respiration in brain mitochondria by nitric oxide and dihydroxyphenylacetic acid (DOPAC). Implications for Parkinson's disease. Neurochem Int 47 (2005) 173-182
38. Pennathur S., Jackson-Lewis V., Przedborski S., and Heinecke J.W. Mass spectrometric quantification of 3-nitrotyrosine, ortho-tyrosine, and o,o-dityrosine in brain tissue of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice, a model of oxidative stress in Parkinson's disease. J Biol Chem 274 (1999) 34621-34628
39. Perry T.L., and Yong V.W. Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients. Neurosci Lett 67 (1986) 269-274
40. Prasad K.N., Carvalho E., Kentroti S., Edwards-Prasad J., Freed C., and Vernadakis A. Establishment and characterization of immortalized clonal cell lines from fetal rat mesencephalic tissue. In Vitro Cell Dev Biol Anim 30A (1994) 596-603
41. Raichur A., Vali S., and Gorin F. Dynamic modeling of alpha-synuclein aggregation for the sporadic and genetic forms of Parkinson's disease. Neuroscience 142 (2006) 859-870
42. Rice M.E., and Russo-Menna I. Differential compartmentalization of brain ascorbate and glutathione between neurons and glia. Neuroscience 82 (1998) 1213-1223
43. Saybasili H., Yuksel M., Haklar G., and Yalcin A.S. Effect of mitochondrial electron transport chain inhibitors on superoxide radical generation in rat hippocampal and striatal slices. Antioxid Redox Signal 3 (2001) 1099-1104
44. Sayre L.M., Smith M.A., and Perry G. Chemistry and biochemistry of oxidative stress in neurodegenerative diseases. Curr Med Chem 8 (2001) 721-738
45. Schapira A.H., Cooper J.M., Dexter D., Clark J.B., Jenner P., and Marsden C.D. Mitochondrial complex I deficiency in Parkinson's disease. J Neurochem 54 (1990) 823-827
46. Schilling B., Bharath M.M.S., Row R.H., Murray J., Cusack M.P., Capaldi R.A., Freed C.R., Prasad K.N., Andersen J.K., and Gibson B.W. Rapid purification and mass spectrometric characterization of mitochondrial NADH dehydrogenase (complex I) from rodent brain and a dopaminergic neuronal cell line. Mol Cell Proteomics 4 (2005) 84-96
47. Schultz B.E., and Chan S.I. Structures and proton-pumping strategies of mitochondrial respiratory enzymes. Annu Rev Biophys Biomol Struct 30 (2001) 23-65
48. Sherer T.B., Betarbet R., Testa C.M., Seo B.B., Richardson J.R., Kim J.H., Miller G.W., Yagi T., Matsuno-Yagi A., and Greenamyre J.T. Mechanism of toxicity in rotenone models of Parkinson's disease. J Neurosci 23 (2003) 10756-10764
49. Smeyne R.J., and Jackson-Lewis V. The MPTP model of Parkinson's disease. Brain Res Mol Brain Res 134 (2005) 57-66
50. Smith M.A., Richey Harris P.L., Sayre L.M., Beckman J.S., and Perry G. Widespread peroxynitrite-mediated damage in Alzheimer's disease. J Neurosci 17 (1997) 2653-2657
51. Sriram K., Shankar S.K., Boyd M.R., and Ravindranath V. Thiol oxidation and loss of mitochondrial complex I precede excitatory amino acid mediated neurodegeneration. J Neurosci 18 (1998) 10287-10296
52. Trounce I.A., Kim Y.L., Jun A.S., and Wallace D.C. Assessment of mitochondrial oxidative phosphorylation in patient muscle biopsies, lymphoblasts, and transmitochondrial cell lines. Methods Enzymol 264 (1996) 484-509